Want to see ANTX full AI Analyst Report?
AN2 Therapeutics, Inc. (ANTX) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| An2-502998 | Healthy Volunteers | Phase I | Recruiting | First-in-Human Trial of Oral AN2-502998 | May 31, 2025 | ― |
| Epetraborole | Mac Lung Disease, Treatment Refractory Mac Lung Disease | phase2AndPhase3 | Terminated | Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease | Mar 24, 2022 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| An2-502998 | Phase I | Healthy Volunteers | Recruiting | First-in-Human Trial of Oral AN2-502998 | May 31, 2025 | ― |
| Epetraborole | phase2AndPhase3 | Mac Lung Disease, Treatment Refractory Mac Lung Disease | Terminated | Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease | Mar 24, 2022 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does AN2 Therapeutics, Inc. (ANTX) have in its pipeline
AN2 Therapeutics, Inc. ANTX is currently developing the following drugs: An2-502998, Epetraborole. These drug candidates are in various stages of clinical development as the company works toward FDA approval.